Skip to main content
Clinical Trials/NCT02242136
NCT02242136
Completed
N/A

Formation, Orientation and Rehabilitation by Means of Narrative Exposure Therapy (FORNET) for Returning Soldiers of the African Union Mission to Somalia, Male and Female Ex-combatants in Burundi

University of Konstanz1 site in 1 country56 target enrollmentSeptember 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Posttraumatic Stress Disorder
Sponsor
University of Konstanz
Enrollment
56
Locations
1
Primary Endpoint
Change from baseline in the extend of appetitive aggression assessed via the Appetitive Aggression Scale (AAS)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Soldiers deployed in peace-keeping missions as well as ex-combatants in conflict or former conflict regions were and are often exposed to multiple traumatic events and situations in which they are forced to engage in violent behavior. The treatment program Formation, Orientation and Rehabilitation by means of Narrative Exposure Therapy (FORNET) is a short-term, culturally sensitive treatment approach that aims to reduce Posttraumatic Stress Disorder (PTSD) symptoms as well as the risk to engage in uncontrolled violent behavior. Addressing trauma-related mental disorders as well as emotions related to aggression by means of FORNET is expected to facilitate reintegration in civil life and reduce uncontrolled violence.

The investigators want to provide evidence, that FORNET is an effective and efficient module to assist soldiers after deployment in Somalia and/or male and female ex-combatants who fought in the civil war in Burundi. In addition the investigators aim to explore how traumatic incidences and maltreatment during childhood may influence treatment outcomes.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
October 2015
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University of Konstanz
Responsible Party
Principal Investigator
Principal Investigator

Anselm Crombach

Principal Investigator

University of Konstanz

Eligibility Criteria

Inclusion Criteria

  • High degree of symptoms of posttraumatic stress disorder according to the Posttraumatic Symptom Scale,
  • High degree of appetitive aggression,
  • Violent behavior during the past three months

Exclusion Criteria

  • Current use of mind altering drugs,
  • Psychotic symptoms

Outcomes

Primary Outcomes

Change from baseline in the extend of appetitive aggression assessed via the Appetitive Aggression Scale (AAS)

Time Frame: baseline, two follow-up assessments are planned within the period of 3 to 12 months post-treatment. Exact time of follow-up will be varied systematically within this period.

Change in number of committed violent acts during the past three months assessed via the Domestic and Community Violence Checklist (DCVC)

Time Frame: baseline, two follow-up assessments are planned within the period of 3 to 12 months post-treatment. Exact time of follow-up will be varied systematically within this period.

Change in Diagnosis and load of PTSD symptoms assessed via the Posttraumatic Symptom Scale - Interview (PSS-I)

Time Frame: baseline, two follow-up assessments are planned within the period of 3 to 12 months post-treatment. Exact time of follow-up will be varied systematically within this period.

Secondary Outcomes

  • Change in physical health complains(baseline, two follow-up assessments are planned within the period of 3 to 12 months post-treatment. Exact time of follow-up will be varied systematically within this period.)
  • Change in strength of suicidal ideation measured via the Mini International Neuropsychiatric Interview (M.I.N.I.)(baseline, two follow-up assessments are planned within the period of 3 to 12 months post-treatment. Exact time of follow-up will be varied systematically within this period.)
  • Change from baseline in load of depressive symptoms assessed via the Patient Health Questionnaire-9 (PHQ-9)(baseline, two follow-up assessments are planned within the period of 3 to 12 months post-treatment. Exact time of follow-up will be varied systematically within this period.)

Study Sites (1)

Loading locations...

Similar Trials